Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001708599-25-000027
Filing Date
2025-03-24
Accepted
2025-03-24 16:14:36
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K age-20241231.htm   iXBRL 10-K 2685735
2 EX-3.1 serinaamendedandrestatedce.htm EX-3.1 48356
3 EX-10.41 serina-stockpurchaseagreem.htm EX-10.41 104716
4 EX-19.1 serina-insidertradingpolic.htm EX-19.1 90544
5 EX-21.1 serinalistofsubsidiariesex.htm EX-21.1 5928
6 EX-23.1 ser-20241231xexx231.htm EX-23.1 2533
7 EX-31.1 ser-20241231xexx311.htm EX-31.1 9941
8 EX-31.2 ser-20241231xexx312.htm EX-31.2 10385
9 EX-32 ser-20241231xexx32.htm EX-32 4933
10 EX-97.1 serinatherapeutics-clawbac.htm EX-97.1 32284
16 age-20241231_g1.jpg GRAPHIC 84435
17 age-20241231_g2.jpg GRAPHIC 24087
18 age-20241231_g3.jpg GRAPHIC 18031
19 age-20241231_g4.jpg GRAPHIC 18023
20 age-20241231_g5.jpg GRAPHIC 5817
21 age-20241231_g6.jpg GRAPHIC 16562
22 age-20241231_g7.jpg GRAPHIC 21363
  Complete submission text file 0001708599-25-000027.txt   11399133

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT age-20241231.xsd EX-101.SCH 66087
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT age-20241231_cal.xml EX-101.CAL 90396
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT age-20241231_def.xml EX-101.DEF 295640
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT age-20241231_lab.xml EX-101.LAB 841949
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT age-20241231_pre.xml EX-101.PRE 604616
108 EXTRACTED XBRL INSTANCE DOCUMENT age-20241231_htm.xml XML 1244330
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38519 | Film No.: 25764329
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)